Gefitinib Interactions
There are 248 drugs known to interact with gefitinib, along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 38 are major, 205 are moderate, and 5 are minor.
- View all 248 medications that may interact with gefitinib
- View gefitinib alcohol/food interactions (1)
- View gefitinib disease interactions (6)
Most frequently checked interactions
View interaction reports for gefitinib and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Abraxane (paclitaxel protein-bound)
- Acetylsalicylic Acid (aspirin)
- Acetylsalicylic Acid (aspirin)
- Activated Charcoal (charcoal)
- Activated Charcoal (charcoal)
- Adrenalin (epinephrine)
- Adrenalin (epinephrine)
- Amoxil (amoxicillin)
- Amoxil (amoxicillin)
- Coenzyme Q10 (ubiquinone)
- Coenzyme Q10 (ubiquinone)
- Dextrose (glucose)
- Dextrose (glucose)
- Diltiazem Hydrochloride SR (diltiazem)
- Diltiazem Hydrochloride SR (diltiazem)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Paracetamol (acetaminophen)
- Valproate Sodium (valproic acid)
- Valproate Sodium (valproic acid)
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin B6 (pyridoxine)
- Vitamin K (phytonadione)
- Vitamin K (phytonadione)
Gefitinib alcohol/food interactions
There is 1 alcohol/food interaction with gefitinib.
Gefitinib disease interactions
There are 6 disease interactions with gefitinib which include:
- dermatologic toxicities
- GI disorders
- ocular disorders
- pulmonary toxicity
- liver disease
- renal dysfunction
Report options
More about gefitinib
- gefitinib consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Tagrisso
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose ...
Docetaxel
Docetaxel systemic is used for breast cancer, breast cancer, metastatic, gastric cancer, head and ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Paclitaxel
Paclitaxel systemic is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
